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The ability to repair damaged or lost tissues varies significantly among vertebrates. The regenerative ability of the
heart is clinically very relevant, because adult teleost fish and amphibians can regenerate heart tissue, but we
mammals cannot. Interestingly, heart regeneration is possible in neonatal mice, but this ability is lost within 7
days after birth. In zebrafish and neonatal mice, lost cardiomyocytes are regenerated via proliferation of spared,
differentiated cardiomyocytes. While some cardiomyocyte turnover occurs in adult mammals, the cardiomyocyte
production rate is too low in response to injury to regenerate the heart. Instead, mammalian hearts respond to
injury by remodeling of spared tissue, which includes cardiomyocyte hypertrophy. Wnt/β-catenin signaling plays
important roles during vertebrate heart development, and it is re-activated in response to cardiac injury. In this
review, we discuss the known functions of this signaling pathway in injured hearts, its involvement in cardiac fibrosis
and hypertrophy, and potential therapeutic approaches that might promote cardiac repair after injury by modifying
Wnt/β-catenin signaling. Regulation of cardiac remodeling by this signaling pathway appears to vary depending on
the injury model and the exact stages that have been studied. Thus, conflicting data have been published regarding a
potential role of Wnt/β-catenin pathway in promotion of fibrosis and cardiomyocyte hypertrophy. In addition, the Wnt
inhibitory secreted Frizzled-related proteins (sFrps) appear to have Wnt-dependent and Wnt-independent roles in the
injured heart. Thus, while the exact functions of Wnt/β-catenin pathway activity in response to injury still need to be
elucidated in the non-regenerating mammalian heart, but also in regenerating lower vertebrates, manipulation of the
pathway is essential for creation of therapeutically useful cardiomyocytes from stem cells in culture. Hopefully, a
detailed understanding of the in vivo role of Wnt/β-catenin signaling in injured mammalian and non-mammalian
hearts will also contribute to the success of current efforts towards developing regenerative therapies.
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All organisms have evolved means of repairing tissue
loss after injury or disease. In most species, healing of
epidermal wounds and other epithelia is an efficient re-
pair process, whereas the ability to recuperate the dam-
age in other tissues varies widely. Mammals (including
humans) can repair injury of skeletal muscle, regenerate
large parts of the liver, and repair damage to the epithelia
of the kidney and the lung but have limited regenerative
capacity in other organs [1]. In contrast, other vertebrates,
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limbs and tails and repair damage to the lens, the retina,
and the central nervous system [2–5]. Importantly, zebra-
fish and newts can also replace lost heart tissue in adults.
A thorough understanding of the cellular and molecular
mechanisms of regeneration in urodele amphibia and fish
is therefore very likely to be informative for the develop-
ment of regenerative therapies in humans.
One of the pivotal signaling pathways regulating the re-
generative process in many systems is the Wnt/β-catenin
signaling pathway. In addition, Wnt/β-catenin signaling is
activated in response to cardiac injury in adult mammals
and plays important roles in hypertrophy and cardiac re-
modeling [6]. Here, we review the cellular mechanisms
underlying heart regeneration in lower vertebrates and the
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vertebrates.
Mammalian heart injury responses
The adult mammalian heart has a very limited capacity
to repair loss of cardiomyocytes (CMs) after infarction
or cardiac overload disorders [7]. In contrast, adult zeb-
rafish can regenerate the heart in response to several in-
jury paradigms, including surgical removal of myocardial
tissue, cryoinjury, and genetic ablation of cardiomyocytes
[3, 8–12]. Intriguingly, neonatal mice can regenerate the
myocardium after partial surgical resection as well, but
this ability is lost by 7 days after birth [13]. During both
zebrafish and neonatal mouse heart regeneration, differ-
entiated CMs re-enter the cell cycle to proliferate and
genetic lineage tracing experiments indicate that the ma-
jority of the newly forming myocardium is derived from
pre-existing CMs [13–15]. Thus, zebrafish and neonatal
mice regenerate lost myocardium not by differentiation
of CMs from progenitor cells but by activating the re-
entry of differentiated CMs into the cell cycle. In contrast,
adult mammalian CMs have long been thought to be ter-
minally differentiated and thus post-mitotic [16–18] and
much of the growth of the postnatal mammalian heart oc-
curs via enlargement of pre-existing CMs, i.e., hypertrophy
[18, 19]. While some studies in adult mouse and human
myocardial cells have suggested that certain CMs are not
terminally differentiated and can reinitiate the cell cycle
under physiological or pathological conditions [20–22],
others have found little evidence for CM proliferation in
the adult heart [23–25]. Indeed, using transgenic mice that
facilitated unambiguous identification of CM nuclei, Soon-
paa and Field found that only 1 out of 180.000 adult
mouse ventricular CMs incorporate [3H] thymidine, and
this increased to only 3 in 36.000 nuclei (0.0083 %) in the
injured heart [23–25]. The consensus conclusion from
these and other studies is that DNA synthesis is very rare
in differentiated adult rodent CMs even after injury, and
CM hypertrophy after injury appears to largely occur with-
out increase in DNA content in the adult heart [24, 26].
Nevertheless, there is good evidence that some new
CMs do form during adult mammalian life, including
humans. A pulse of atmospheric carbon-14 (14C) was gen-
erated by nuclear bomb tests during the Cold War and
rapidly declined after atmospheric tests were banned.
Since 14C makes its way through the food chain into hu-
man cells, the 14C levels found in DNA of human CMs
corresponds to the atmospheric levels at the time when
these cells were born. Bergmann and colleagues have mea-
sured the 14C concentrations in DNA of human myocar-
dial cells [27]. They have found that in subjects born up to
22 years before the onset of bomb tests, 14C concentra-
tions were elevated compared to the levels before the
tests, indicating that myocardial cells contained DNAsynthesized years after birth. Thus, human CMs are cap-
able of renewal during adulthood [27]. CM renewal, how-
ever, is very slow as estimated from this study; 1 % of the
CMs are renewed per year at the age of 25 and only
0.45 % at the age of 75. Thus, approximately 45 % of all
CMs are exchanged during a human lifetime while 55 %
remain from neonatal stages [27].
While it is not possible to identify the cellular source
of newly forming CMs in the adult human heart, several
studies in mice have addressed whether CM renewal
during homeostasis and the low-rate CM replacement
after cardiac injury are due to proliferation of existing
CMs or due to CM differentiation from progenitor cells
[26, 28–33]. Unfortunately, the conclusions drawn by
several studies based on genetic lineage tracing of CMs
or cardiac progenitor cells differ considerably. While
most reports using different means to track the fate of
differentiated CMs conclude that renewal of CMs during
homeostasis is due to proliferation of existing CMs [26],
one study concluded that progenitor cells contribute to
CM formation after cardiac injury, since the progeny of
differentiated CMs get diluted with other cells in injured
hearts [28]. In contrast, other studies using lineage tracing
of differentiated CMs and multi-isotope imaging mass
spectrometry concluded that the limited CM replacement
after injury is due to CM proliferation [29, 32]. However,
c-kit-positive cardiac progenitor cells have been reported
to contribute significantly to CM production after cardiac
injury as well [30]. In contrast, another study found that
c-kit-positive cells form negligible numbers of CMs both
during homeostasis and after injury [33]. The dissimilar
results obtained by these studies are a reminder of the fact
that albeit genetic lineage tracing tools are the most
powerful way to address questions of cellular lineage, each
tool needs to be very critically evaluated. In particular, it is
possible that some Cre lines are not specifically expressed
in a particular cell type; Cre expression could cause tox-
icity, and the fact that most tools fail to label all cells of a
particular cell population could result in failure to appre-
ciate that the labeled population is actually heterogeneous.
Yet, while further studies are needed to clarify how CMs
are formed in the adult mammalian heart, the consensus
is that the rate of CM formation is too low to result in sig-
nificant myocardial regeneration after heart injury [26].
A possible reason for the failure of adult mammalian
CMs to sufficiently proliferate in response to cardiac
insult might be their increased DNA content. Most adult
mammalian CMs contain more than two sets of chromo-
somes. Starting at 4 days post birth, rodent CMs grow and
become binucleated with each nucleus remaining diploid
[18]. In contrast, most human CMs maintain a single nu-
cleus, which however increases its DNA content to tetra-
ploidy or even higher ploidy [34–36]. Binucleation, as
seen in rodents, likely represents an impediment to
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the proliferation of binucleated CMs has been reported as
well [37]. Polyploidy of mononucleated cells might acti-
vate cell cycle arrest [38], yet many animal species exist as
polyploids [39]; thus, non-diploid DNA content should
not represent a principal impediment for cellular prolifer-
ation, although it possibly does in CMs. Intriguingly, ex-
perimental manipulation of several cell cycle proteins as
well as activation of a variety of signaling pathways includ-
ing Notch, neuregulin1/ErbB4, Fgf-1, Pi3K, and Akt sig-
naling can stimulate cell cycle re-entry in differentiated
mature mammalian CMs [40–45]. Yet, not all CMs that
are driven by these regimes into DNA synthesis undergo
cytokinesis, and at least for the case of neuregulin, it is
clear that only mononucleated mouse CMs, which repre-
sent less than 10 % of adult CMs, could be stimulated.
Nevertheless, constitutive activation of cyclin A2 and acti-
vation of neuregulin1/ErbB4, PI3K, and Akt have also
been shown to promote cardiac repair and heart function
upon myocardial infarction [41, 43, 46]. Thus, while adult
mammalian hearts fail to activate a regenerative program
of CM proliferation in response to myocardial injury, adult
CMs appear to have no intrinsic block preventing their
proliferation. This raises the possibility that therapeutic al-
teration of the signaling environment of the injured heart
could activate compensatory proliferation of CMs.
The Wnt/β-catenin signaling pathway
Wnt/β-catenin signaling has vital functions during em-
bryonic development, adult homeostasis, and tissue and
organ regeneration [47, 48]. The pathway takes its name
from a family of secreted glycoproteins, the Wnt proteins,
which act as pathway ligands and from the downstream
effector molecule, β-catenin [49, 50]. In the absence of an
active Wnt ligand, i.e., in the Wnt-off state, β-catenin is
phosphorylated by a cytoplasmic complex of proteins (the
“destruction complex”) that includes two serine/threonine
kinases, namely Glycogen synthase kinase 3β (Gsk3β) and
Casein kinase 1 (Ck1); the scaffolding protein Axin; and
the tumor suppressor Adenomatous polyposis coli (Apc)
(Fig. 1) [51, 52]. Phosphorylated β-catenin is ubiquitinated
and targeted for degradation by the proteasome pathway
[47, 50, 53, 54]. If active Wnt ligands are available, i.e., in
the Wnt-on state, they interact with Frizzled (Fz) recep-
tors and the coreceptor Low-density lipoprotein receptor-
related proteins 5/6 (Lrp5/6) [51, 55]. Lrp5/6 is then
phosphorylated at its intracellular domain by Gsk3β and
Ck1 in raft plasma membrane domains and internalized
into intracellular vesicles [47, 56–58]. Lrp5/6 phosphoryl-
ation recruits the cytoplasmic scaffolding proteins Dishev-
elled (Dvl) and Axin to the receptor complex, leading to
inhibition of the destruction complex and hence inhibition
of β-catenin phosphorylation (Fig. 1) [51, 59]. This results
in β-catenin stabilization in the cytoplasm and itstranslocation into the nucleus, which is in part mediated
by Fam53b/Smp [60]. β-catenin regulates target gene ex-
pression with the transcription factors of the T cell factor
(Tcf)/Lymphoid enhancer factor (Lef) family [47, 51, 61,
62]. The Wnt-off-state can also be brought about by a
plethora of pathway inhibitors [63, 64], some of which act
by binding to the Wnt ligands, such as secreted Frizzled-
related proteins (sFrps) and Wnt inhibitory factor (Wif)
[65].
Wnt signaling in heart development
Wnt/β-catenin signaling plays essential roles during ver-
tebrate heart development [66]. Several studies have un-
covered an inhibitory role of Wnt/β-catenin signaling in
vertebrate heart specification, which is most dramatically
revealed by the formation of ectopic hearts after condi-
tional inactivation of β-catenin in the definitive endo-
derm of the mouse embryo [67]. However, during the
last years, studies in zebrafish and mouse embryos and
mouse and human embryonic stem cells (hESCs) have
identified temporally distinct roles for Wnt/β-catenin
signaling during vertebrate heart development. Accord-
ing to this model, the pathway induces cardiac specifica-
tion during early developmental stages but inhibits it
later [66, 68–72] (Fig. 2). Thus, treatment of early differen-
tiating mouse or human ES cell cultures with Wnt ligands
enhances CM formation via promotion of mesoderm spe-
cification, while later treatment with Wnts suppresses and
the Wnt inhibitor Dickkopf1 (Dkk1) promotes CM differ-
entiation [68, 70–72] (Fig. 2). Likewise, the cardiomyocyte
progenitor cell (CMPC) marker Mesp1 drives cardiac dif-
ferentiation of ES cells via directly activating Dkk1 expres-
sion [73]. These findings are highly relevant for efforts to
produce human CMs for therapeutic transplantation from
ES or induced pluripotent stem cells (iPSCs) in culture.
Less is known about potential roles of Wnt/β-catenin
signaling in the regulation of CM proliferation. Treat-
ment of neonatal or adult rat CMs in culture with the
Gsk3 inhibitory small molecule BIO, which, among other
effects, results in stabilization of β-catenin, can induce cell
proliferation and mitosis [74]. Evidence that Wnt/β-catenin
signaling regulates CM proliferation in vivo comes from a
genetic study in mouse. Inactivation of the Hippo pathway,
which restrains cell proliferation and thus controls organ
size in Drosophila, in the embryonic mouse heart results in
development of enlarged hearts which display increased
numbers of CMs and increased CM proliferation [75].
Intriguingly, β-catenin levels are upregulated in such hearts
and deletion of one copy of β-catenin can rescue the heart
overgrowth phenotype. Thus, Wnt/β-catenin signaling
might promote CM proliferation and is kept in check by
the Hippo pathway. However, since Hippo and β-catenin
were conditionally deleted in nkx2.5+ cardiomyocyte pre-
cursor cells early during heart development in this study, it
Fig. 1 The Wnt/β-catenin signaling pathway. In the Wnt-off state, defined by the absence of an active Wnt ligand, β-catenin is phosphorylated
by the destruction complex (formed from the two kinases Gsk3 and Ck1, the scaffolding protein Axin, and the tumor suppressor Apc) and
degraded by the ubiquitin-proteasome pathway. In the Wnt-on state, active Wnt ligands interact with the Fz receptors and the Lrp5/6 coreceptor.
Phosphorylation of Lrp5/6 by Gsk3 and Ck1 recruits Dvl and Axin to the receptor complex and hence inhibits the destruction complex. This, in
turn, inhibits β-catenin phosphorylation and stabilizes β-catenin in the cytoplasm. β-catenin is then translocated into the nucleus, by a complex
including Fam53b/Smp, and regulates target gene expression with the Tcf/Lef transcription factors. Many modulators including the inhibitors
sFrps and Wif are known to tightly regulate the signaling cascade
Fig. 2 Roles of Wnt/β-catenin signaling during vertebrate heart development. Wnt/β-catenin signaling is required for heart development in a
biphasic manner: while the activation of the pathway promotes mesoderm specification in early phases of hESC differentiation, it hampers CM
differentiation at later stages. This late-stage suppression can act through the cardiac differentiation inducer Mesp1, which activates the Wnt
inhibitor Dkk1. Wnt/β-catenin signaling can also regulate CM proliferation through Gsk3 by regulating β-catenin activity
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proliferation or differentiation and do not directly control
CM proliferation.
Activation of the Wnt/β-catenin signaling
pathway in response to cardiac injury
Heart injuries caused by myocardial infarction, pressure/
volume overload, inflammatory diseases, cardiomyopathy,
chronic hypertension, or congenital heart disease mostly
affect the ventricles and lead to complex responses including
scarring, fibrosis, and CM hypertrophy in mammals, which
are generally referred to as ventricular remodeling. These
changes cause a decline in the ventricular performance and
contractile function, which can result in heart failure.
In addition to its role during cardiac development,
Wnt/β-catenin signaling has also been implicated in regu-
lation of cardiac remodeling and injury responses in mam-
mals. While there is a body of work suggesting roles for
Wnt/β-catenin signaling in protection of CMs from apop-
tosis and regulation of CM hypertrophy, there is little evi-
dence supporting a direct role of the pathway in these
processes. Furthermore, several of the Wnt pathway com-
ponents shown to play a role in the cardiac injury response,
in particular Gsk3 and sFrps, have additional functions un-
related to Wnt signaling, which perplex the situation.
Several studies have shown that the expression of
Wnt ligands and of the feedback regulators Dkk1 and
Dkk2 is induced in response to injury of the mouse
heart [76–78]. Aisagbonhi and colleagues described in-
duction of Wnt-2, Wnt-4, Wnt-10b, and Wnt-11 5 days
post permanent left anterior descending (LAD) coron-
ary artery occlusion in whole heart samples [76], while
Duan and colleagues reported that Wnt-1 is robustly in-
duced 2 days post injury and sustained in entire hearts
in response to transient LAD occlusion, whereas Wnt-4
and Wnt-7a are only upregulated transiently at later
stages [78]. It is surprising that these two studies only
agree on Wnt-4 as an injury response gene. Further
gene expression studies performed on transiently and
permanently occluded hearts in parallel will be needed
to clarify whether these discrepancies are due to the dif-
ferent injury models used. β-catenin levels have also
been reported to increase in rat hearts starting 1 day
post pressure overload induced by thoracic aortic con-
striction (TAC) [79]. Although functional roles of Wnt/
β-catenin signaling during cardiac repair have been
studied since about a decade, the sites of Wnt pathway
activation in the injured heart have been analyzed only
recently [76, 78, 80]. Using the Axin2-LacZ mouse, which
expresses the marker LacZ under control of regulatory el-
ements of Axin2, which is considered a universal Wnt
feedback target gene, and thus serves as useful readout of
β-catenin signaling activity, upregulation of pathway activ-
ity was reported after permanent LAD in endothelial cells,Sca-1 and c-kit-positive progenitors, fibroblasts, and
smooth muscle cells; LacZ+ cells were mainly found in
the infarct border zone starting at 7 days post injury (dpi),
peaking at 14 dpi [80]. In addition, LacZ+ leukocytes
started to accumulate at 3 dpi. Using the TopGAL mouse,
upregulation of pathway activity could be detected 4 days
after permanent LAD in subepicardial endothelial cells
[76]. One week after injury, myofibroblasts expressing the
TopGAL reporter accumulated in the infarct area, and
genetic lineage tracing showed that these were derived
from endothelial cells that appeared to undergo an
endothelial-to-mesenchymal transition (EndMT) [76]. In
contrast, TopGAL activity was reported in response to
ischemia-reperfusion caused by transient LAD ligation
primarily in the epicardium [76, 78, 80]. Since the different
Wnt reporter mouse lines have been reported to display
contrasting expression patterns in some tissues [81], a de-
finitive determination of active sites of Wnt/β-catenin sig-
naling in the injured mammalian heart will likely require
the side-by-side comparison of different reporter mice
using identical injury models and detection methods plus
determination of endogenous target gene expression in
isolated cardiac cell populations.
A role for Wnt/β-catenin signaling in fibrosis
Although the studies by Aisagbonhi et al. and Duan
et al. identified different primary sites of Wnt/β-catenin
signaling induction in response to permanent LAD (sub-
epicardial endothelium) and transient LAD (the epicar-
dium), they surprisingly both define a functional role of
Wnt/β-catenin signaling in promoting fibroblast forma-
tion from these cells in a process of endothelial or
epithelial-to-mesenchymal transition (EndMT and EMT
respectively) [76, 78]. In cultured endothelial cells, treat-
ment with the Gsk3 inhibitor BIO, which induced direct
β-catenin target genes and activity of the transcriptional
Wnt reporter Topflash, was sufficient to induce EndMT
and myofibroblast formation as evidenced by reduction
of endothelial markers and induction of smooth muscle
actin [76]. Likewise, Wnt-1 overexpression promoted
EMT and fibroblast differentiation of cultured epicardial
cells, while β-catenin deletion in epicardial cells reduced
epicardial expansion and EMT in response to injury and
resulted in reduced cardiac function [78]. Furthermore,
β-catenin deletion in cardiac fibroblasts reduced their
number in ischemia-reperfusion injured hearts and like-
wise caused cardiac dysfunction. Together, these data in-
dicate that Wnt/β-catenin signaling promotes fibrosis in
response to injury via inducing the transition to a mes-
enchymal state of both endothelial and epicardial cells;
fibrosis, in turn, appears to be required to stabilize the
wound and prevent cardiac dilation. Interestingly, Wnt/
β-catenin signaling activation has also been reported in
fibrotic diseases of the lung, liver, and kidney and Wnt/
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tial for differentiation of fibroblasts into myofibroblasts
and production of collagen by these cells [82, 83]. It will
be very interesting to test whether Wnt/β-catenin signal-
ing plays different roles in systems like the zebrafish or
postnatal mice that activate a regenerative program ra-
ther than fibrosis in response to injury.
A role for Wnt/β-catenin signaling in CM
hypertrophy
Whether CMs activate Wnt/β-catenin signaling at later
stages after infarction requires further investigation: while
LacZ reactivity has been reported in heart regions contain-
ing CMs in the Axin2-LacZ mice, the identity of these cells
was not confirmed by marker gene expression and the LacZ,
which is targeted to the nucleus in these mice, was found in
the cytoplasm in the presumptive CMs, raising questions
about the validity of these results [80]. Furthermore, no CM
expression was reported in the TopGAL mice [76, 78].
Thus, while activation of the β-catenin-dependent path-
way in CMs in response to myocardial infarction in vivo
has not been shown, functional evidence exists for an in-
volvement of Wnt/β-catenin signaling in injury or stress-
induced CM hypertrophy. However, conflicting data have
been reported on whether β-catenin is required or actually
inhibits CM hypertrophy. On one hand, several studies
support a hypertrophy-promoting role for Wnt/β-catenin
signaling. Conditional, CM-specific depletion of β-catenin
in adult mice was found to impair CM hypertrophy in re-
sponse to pressure overload induced by thoracic aortic
constriction, while non-conditional transgenic overexpres-
sion of a dominant-negative Lef transcription factor in
CMs throughout embryonic development resulted in CM
hypotrophy [78]. Furthermore, transgenic overexpression
of Gsk3 (which among other effects might inhibit β-
catenin signaling) suppressed CM hypertrophy in re-
sponse to stress [84]. β-catenin was found to be stabilized
in cultured CMs in response to hypertrophic stimuli
(phenylephrine or endothelin-1) due to inactivation of
Gsk3 activity, but interestingly not in a Wnt pathway-
dependent manner but rather via phosphorylation of Gsk3
at serine 9 by Protein kinase B (PtB) [85]. β-catenin
knockdown also reduced phenylephrine-induced CM
hypertrophy in cultured cells, possibly since upregulation
of the fetal gene anf in response to phenylephrine is dir-
ectly regulated by Lef1/β-catenin [86]. Contradicting a
role for Wnt/β-catenin signaling in the promotion of
hypertrophy are two studies using conditional deletion of
β-catenin. β-catenin deletion in CMs did not impair CM
hypertrophy in response to angiotensin II infusion [87].
On the contrary, mice expressing a constitutively active,
stabilized β-catenin in CMs (achieved via conditional
deletion of exon 3 of β-catenin, which codes for the
domain phosphorylated by GSK3β) showed an abrogatedhypertrophic response to angiotensin II [87]. Furthermore,
the same mouse β-catenin deletion and overexpression
models showed no alterations in CM hypertrophy at 2
and 4 weeks after infarct [88]. Currently, it remains unex-
plored whether the discrepancy between these and the
above-mentioned studies showing a requirement for β-
catenin for hypertrophy in response to thoracic aortic
constriction can be explained by the different molecular
responses induced by the different injury and stress
models used.
Interestingly, treatment of cultured neonatal and adult
mammalian CMs with the small Gsk3 inhibitor BIO,
which results in β-catenin stabilization, has been found
to be sufficient to induce CM proliferation [74]. Non-
conditional Gsk3 knockout mice lacking Gsk3 throughout
development display a CM hyperproliferation phenotype
without defects in CM size [89]. Together with the data
discussed above on the interaction of the Hippo and β-
catenin pathways, these results indicate that Gsk3, possibly
via reducing Wnt/β-catenin signaling, negatively regulates
CM proliferation during embryonic development, a role
that can be re-activated in adult CMs, at least in culture.
This stands in contrast to the evidence supporting a posi-
tive role of Gsk3 inhibition and Wnt/β-catenin signaling
in CM hypertrophy in the stressed adult myocardium.
Additional conditional in vivo loss-of-function data will be
required to clarify whether β-catenin function switches
from CM proliferation-promoting in the embryo to hyper-
trophy-promoting in the adult.
Wnt pathway-dependent and Wnt pathway-
independent roles of sFrps
Expression of several sFrps, which can act as inhibitors
of Wnt signaling pathways, is elevated in mouse models
of myocardial infarction (MI) generated by LAD and in
overload-induced failing human hearts [77, 90, 91]. How-
ever, functional data on the role of sFrps in mammalian
heart remodeling and repair indicate that their role is
highly complex and that they might in fact act as activa-
tors of Wnt/β-catenin signaling but also have important
Wnt signaling-independent functions. Delivery of mesen-
chymal stem cells expressing Akt can improve cardiac
function after infarction [92], and sFrp-2 secreted by these
cells has been shown to be a key mediator of their positive
effects [93]. Intriguingly, sFrp-2 was sufficient to protect
CMs from hypoxia-induced apoptosis and surprisingly in-
creased β-catenin levels in CMs. This result is in accord-
ance with the proposal that sFrps, in addition to their role
as Wnt ligand scavengers, are able to promote Wnt/β-ca-
tenin signaling by enhancing Wnt ligand diffusion [94].
Yet, how recombinant sFrp-2 might promote β-catenin
accumulation in cultured CMs remains unexplained. Fur-
thermore, Mirotsou et al. showed that hypoxic CMs up-
regulate Wnt3a expression, and Wnt3a treatment induced
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which surprisingly would indicate that Wnt3a inhibited
and sFrp-2 activated Wnt/β-catenin signaling in this con-
text (Fig. 3, Wnt-dependent route).
Constitutive overexpression of sFrp-1 in mice has been
shown to reduce infarct size and cardiac function after
coronary artery ligation or cryoinjury [77]. In contrast,
sFrp-1 overexpression specifically in CMs did not affect
infarct size or cardiac function in an ischemia-reperfu-
sion (IR) model [95]. Rather, sFrp-1 expressed in CMs
reversed the cardio-protective effect of pre-conditioning
prior to IR and thus worsened infarcts after pre-condi-
tioning, which stands in contrast to the positive effects
observed after systemic sFrp-1 expression. Whether these
differences are due to the different injury models used in
these studies or reflect a cardio-protective function of
sFrp-1 in non-CMs remains unexplained. sFrp-1 was pro-
posed to activate Gsk3 function in the latter study using
CM-specific sFrp-1 expression, but not via inhibition of
Wnt/β-catenin signaling but by counteracting phosphoryl-
ation and thus inhibition of Gsk3 by a Pi3-kinase-protein
kinase B pathway during cardiac pre-conditioning [95, 96].
This pathway regulates β-catenin-independent cardio-
protective effects of Gsk3. Likewise, no effects on β-catenin
levels were seen after CM-specific sFrp overexpression, in-
dicating that sFrp-1 likely does not modify Wnt/β-catenin
signaling in this context.
Clearly, additional experiments using transcriptional
readouts of β-catenin activity in culture and in vivo plus
loss-of-function experiments will be required to clarify
whether Wnt/β-catenin signaling is cardio-protective
and whether sFrps have an endogenous role as modifiers
of this function. A recent report on the function of the
secreted Wnt inhibitor Dkk3 actually showed that Dkk3
knockout mice had greater infarcts and aggravated left
ventricular function after infarct, while Dkk3 overexpres-
sion protected from infarction [97]. This indicates thatFig. 3 Wnt-dependent and Wnt-independent roles of secreted
Frizzled-related proteins (sFrps). sFrp-2 can block hypoxia-induced
CM apoptosis by activating a Wnt/β-catenin pathway. On the other
hand, sFrp-2 can induce collagen deposition and fibrosis via enhancing
Bmp1 function, which occurs through a Wnt-independent pathwayactive Wnt/β-catenin would exacerbate cardiac injury
and remodeling, while inhibition of β-catenin signaling
by Dkk3 is cardio-protective.
Intriguingly, another Wnt signaling-independent func-
tion of sFrp has been uncovered in regulation of fibrosis
in response to cardiac injury. Mammalian sFrp-2 has
been found to enhance the function of the metallopro-
teinase Bmp1, which is a rate-limiting enzyme in the
processing of pro-collagen during collagen fiber forma-
tion at physiological low concentrations (10–20 nM)
[91] (Fig. 3, Wnt-independent route). Since collagen de-
position is a hallmark of fibrosis occurring after cardiac
injury, sFrp-2 might enhance fibrosis and thus worsen
cardiac function after infarction. Indeed, fibrosis was
found to be reduced and cardiac function to be improved
in sFrp-2 knockout mice after coronary artery ligation
[91]. Remarkably, at high concentrations, sFrp-2 was
found to have the opposite effect: it inhibited Bmp1 activ-
ity and thus collagen deposition, and injection of recom-
binant sFrp-2 into the infarcted area of rats after coronary
artery ligation reduced fibrosis and improved cardiac func-
tion [98]. Thus, sFrps can act through Wnt-dependent or
Wnt-independent pathways and appear to positively or
negatively regulate the cardiac response to different injury
types in a context-dependent manner (Fig. 3).
A role for Wnt/β-catenin signaling in response of
cardiac progenitor cells to injury
As outlined above, conflicting data exist on the in vivo
importance of cardiac progenitor cells for CM formation
during adult homeostasis and in response to heart injury
[22, 24]. Some evidence exists for a role of Wnt/β-catenin
signaling in regulation of progenitor cell differentiation.
Zelarayan et al. reported that conditional depletion of
β-catenin from the adult mouse myocardium using a
MHC-Cre driver line resulted in improved survival and
left ventricular function 4 weeks after chronic LAD [88].
The Cre driver was found to be active in a population of
progenitor cells (as defined by absence of expression of
cardiac Troponin T (cTnT) but presence of proliferation
markers and the embryonic CM transcription factors
Gata4 and Tbx5). β-catenin depleted infarcted hearts
showed increased numbers of cTnT-positive CMs in sube-
picardial and subendocardial positions, which the authors
proposed not to be due to increased survival, proliferation,
or hypertrophy of existing differentiated CMs. Rather, they
found that isolated progenitor cells from β-catenin de-
pleted hearts showed increased tendency to differenti-
ate into cTNT+ cells in coculture with CMs [88].
Thus, β-catenin might inhibit differentiation of cardiac
progenitor cells in the injured heart, consistent with
the negative role of Wnt/β-catenin signaling in the
later phases of heart development. Another recent
study found that injection of recombinant Wnt3a
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crease in infarct size and worsened cardiac perform-
ance, and it was suggested that this is due to a negative
influence of Wnt3a on proliferation of cardiac side
population (sca1+, c-kit−, isl−) progenitor cells [99].
The in vivo relevance of this finding however has not
been assessed using loss-of-function experiments.
Therapeutic interventions on progenitor cells
based on modulation of Wnt/β-catenin signaling
Human pluripotent stem cells (hPSCs), including hESCs
and iPSCs, provide a potentially unlimited supply of pro-
genitor cells that can differentiate into the vast majority
of somatic cell types including CMs [100–102]. Tem-
poral modulation of Wnt/β-catenin signaling via small
molecule inhibitors or shRNA knockdown has been
shown to affect the differentiation of hPSCs to CMs.
Lian and colleagues found that short hairpin RNA
(shRNA) knockdown of β-catenin during the early hPSC
differentiation period arrested CM specification while
small molecule mediated inhibition of GSK3 within the
same period promoted it in multiple hPSC lines [103].
Inhibition of Wnt/β-catenin signaling during later phases
of cardiac differentiation, however, can promote cardiac
differentiation in hPSCs and generate functional CMs
[104–106] as it does during development [66, 68–72].
Wnt/β-catenin signaling has also been reported to con-
tribute to CM differentiation in progenitor cells, other
than hPSCs. Cardiogenol C, a small molecule that was
shown to induce ES cells to differentiate into CMs [107],
was sufficient to promote hair bulge progenitor cells
(HBPCs) to transdifferentiate into CM-like cells most
likely by activating the Wnt/β-catenin pathway through
suppression of Kremen1 [108]. Early treatment of human
iPSCs with Bmp-4 followed by late treatment with small
molecule Wnt inhibitors caused a remarkable increase in
the total yield of biologically functional CMs, suggesting
that modification of Bmp-4 and Wnt/β-catenin signaling
pathways in human iPSCs might create an efficient plat-
form to produce new CMs after cardiac injuries [109].
Similarly, the Cardionogen family of chemicals, which in-
hibit β-catenin-dependent transcription in murine ES cells
and zebrafish embryos, modulated cardiogenesis in a bi-
phasic manner and, while failing to induce CM differenti-
ation during the initial ES cell differentiation period,
increased the number of CMs by expanding the cells in
both systems [110]. Moreover, another Wnt/β-catenin
pathway inhibitor molecule, pyrvinium, was found to re-
duce adverse cardiac remodeling in mice infarcted by
LAD after intracardiac injection, increase proliferation of
differentiated CMs, and hence promote wound repair
[111]. While modulation of the Wnt/β-catenin pathway
thus appears to promote the cardiac differentiation of
hESCs and iPSCs and tissue repair following heart injury,it should be noted that the molecular mechanisms of these
effects remain unclear.
Heart regeneration in the zebrafish model
In contrast to the limited regenerative ability of the adult
mammalian heart, urodele amphibia and teleost fish re-
tain regenerative capacity of the heart throughout adult
life [3, 112]. Most of our knowledge about the mecha-
nisms underlying heart regeneration comes from studies
using zebrafish. While teleost fish have only a two-
chambered heart (one ventricle, one atrium), the cellular
composition, physiology, and development of the fish
heart are well conserved with that of mammals. Due to a
wealth of accumulated knowledge about heart develop-
ment and the availability of many molecular, genetic,
and genomic tools, zebrafish is an excellent model to
study the cellular and molecular mechanisms of heart
regeneration [113–115]. Furthermore, due to their short
generation time, small size, and cheap husbandry, a high
number of individual fish can be studied and transgenic
and mutant lines can be produced quickly and at rela-
tively low cost. The adult zebrafish heart is also easily
accessible for surgical or other experimental manipula-
tions, and the animals are highly tolerant to experimen-
tal cardiac injury [2].
Adult zebrafish hearts have been shown to display
remarkable regenerative capacity in response to three
types of injury: surgical removal of up to 20 % of the
apex of the ventricle, cryoinjury-induced necrosis of up
to 25 % of the apical ventricular region [9, 11, 116], and
even mosaic ablation of up to 70 % of CMs caused by
transgenic expression of diphtheria toxin [12]. In all
three injury regimes, lost CMs are being replaced within
30 to 120 days and no or little permanent collagen-rich
scar tissue forms.
While assays for heart function, in particular assess-
ment of cardiac hemodynamics using ultrasound, are
difficult due to the small size of the zebrafish heart and
thus not trivial to perform [117–119], there is increasing
evidence for functional recovery during zebrafish heart
regeneration. Myocardium at the apex of the ventricle,
which presumably has formed anew during regeneration
in response to ventricular resection, was found to be
electrically coupled to the rest of the ventricle, indicating
functional recovery [14]. Likewise, coupling measured by
optical mapping was found to be restored to pre-injury
levels 45 days post genetic ablation of CMs, as was a
lengthening in action potential duration occurring after
ablation as measured at the tissue level [12]. Electrocar-
diogram recordings indicate that prolonged QT intervals
were measured during recovery after cryoinjury [9].
However, another report found that regenerated hearts
retained a prolonged QT interval after ventricular resec-
tion [120]. Side-by-side comparison of different injury
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electrophysiological properties of individual CMs [121]
will be instrumental in clarifying whether zebrafish can
completely recover the electrophysiology of the heart.
Measurements of cardiac performance based on echocardi-
ography indicate that heart function does recover; yet this
might take longer than morphological regeneration. Here,
one study reported that heart function after cryoinjury re-
covered only within 180 days [122], while another study
showed that pumping fraction based on relative fractional
volume shortening recovered within 60 days in cryoinjured
hearts, while ventricular wall motion remained altered
even after 140 days [123]. Overall, these data indicate that
zebrafish can not only regenerate heart tissue architecture
but also function, albeit it remains somewhat unclear how
complete the functional regeneration is.
The cellular mechanisms activated after wounding and
underlying heart regeneration appear to be highly similar
between the injury models. A few days after injury,
transcriptional responses occur in the entire epicardium,
including upregulation of genes normally expressed dur-
ing development (including Wilms’ tumor 1b), which is
followed by proliferation and expansion of the epicar-
dium into a multilayered structure [9, 11, 12, 116, 124].
Interestingly, similar epicardial responses occur in regen-
erating neonatal mouse hearts [13]. Genetic ablation of
the epicardium has shown that it is essential for myocar-
dial regeneration, but the nature of the molecular signals
mediating its effects on CMs during zebrafish heart
regeneration has not been elucidated [125]. In infarcted
mouse hearts, epicardial Wilms’ tumor 1 (wt1) expres-
sion can also be re-activated by experimental treatment
with the peptide thymosin 4 and wt1-positive cells have
been reported to represent multipotent progenitors that
can give rise to CMs after injury, albeit at a low fre-
quency [126]. In contrast, in the regenerating zebrafish
heart, genetic lineage tracing of epicardial cells identified
by expression of tcf21 showed that epicardial cells give
rise to perivascular cells but not CMs [127]. Thus, natur-
ally occurring myocardial regeneration in the zebrafish
occurs without a cellular contribution of the epicardium.
While regenerating CMs have initially been proposed to
be derived from progenitor cells that do not have CM
character [128], genetic lineage tracing data using the Cre-
Lox system has rather indicated that the entire regener-
ated myocardium is derived from existing, differentiated
CMs [14, 15]. In particular, a subepicardial population of
CMs characterized by expression of a transgene driven by
a gata4 promoter fragment appears to produce the bulk of
the regenerated myocardial tissue [14, 129]. Thus, CMs
dedifferentiate in response to injury, re-enter the cell
cycle, and proliferate to replace the missing tissue.
Although a large body of data shows that Wnt/β-
catenin signaling plays important roles in mammaliancardiac remodeling and regeneration processes occur-
ring in response to heart injury, its potential role in
regulation of zebrafish heart regeneration remains to
be tested. We have previously found that a transgenic
reporter of Wnt/β-catenin signaling is upregulated in
the injured ventricle after ventricular resection [130].
Besides, a novel Wnt target gene simplet (smp), which we
have identified to be necessary for β-catenin-dependent
signal transduction [60], is also transcriptionally activated
in the zebrafish heart after amputation injury [131]. Thus,
while Wnt/β-catenin signaling appears to be linked to
heart regeneration in zebrafish, our efforts to test its func-
tion in heart regeneration using transgenic lines allowing
for heat shock-inducible overexpression of Wnt modifiers
have been confounded by the realization that heart regen-
eration can be impaired by the stress inflicted by heat
shocking the fish (data not shown). Thus, these tools,
which we have successfully used to uncover an essential
function for Wnt/β-catenin signaling in the regulation of
zebrafish fin regeneration [130, 132], are not ideal for the
analysis of heart regeneration. Likely, studies into the role
of Wnt/β-catenin signaling in zebrafish heart regeneration
will benefit from further technological advances allowing
for alternative methods of inducible manipulation of gene
expression [133, 134].
Conclusion
Heart regeneration is a complex process that only occurs
in lower vertebrates, but not in mammals. Several pro-
cesses such as dedifferentiation, proliferation, redifferen-
tiation, and patterning should take place in concert in a
highly regulated manner. Wnt/β-catenin signaling is cru-
cial for orchestration of the regeneration process in
other systems [132, 135]. Therefore, further studies will
likely also uncover a role for Wnt/β-catenin signaling in
lower vertebrate heart repair. Whether its role will be
similar or different to the rather complex functions that
Wnt/β-catenin signaling plays after mammalian heart in-
jury will be interesting to study. Regenerating organisms
such as zebrafish provide an excellent tool to address
these issues, and regenerative therapeutic applications will
surely benefit from a more widespread use of this model.
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